
Roche Holding AG
RHHVF | OTC
$438.80
-$4.50 (-1.02%)
Sep 22, 2026, 1:06 PM ET · Market open
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Revenue | 62.4B | 60.44B | 63.28B | 62.8B | 58.32B | 61.47B |
Cost of Revenue | 16.28B | 16.36B | 20.4B | 19.65B | 16.18B | 18.35B |
Gross Profit | 46.11B | 44.08B | 42.88B | 43.15B | 42.15B | 43.12B |
Operating Income | 13.42B | 15.4B | 17.48B | 18.16B | 18.54B | 17.55B |
Interest Income | 260M | 195M | 67M | 342M | 16M | 102.24M |
Pretax Income | 11.79B | 14.08B | 16.33B | 17.4B | 17.97B | 16.61B |
Net Income | 8.28B | 11.5B | 12.42B | 13.93B | 14.3B | 13.5B |
Selling & General & Admin | 14.9B | 14.88B | 12.53B | 13.25B | 12.61B | 15.08B |
Research & Development | 15.3B | 14.2B | 16.02B | 14.8B | 13.01B | 12.77B |
Other Expenses | 2.5B | -392M | -3.15B | -3.05B | -2.02B | -2.29B |
Operating Expenses | 32.7B | 28.69B | 25.41B | 25B | 23.6B | 25.57B |
Interest Expense | 1.4B | 997M | 690M | 419M | 553M | 640.26M |
Selling & Marketing Expenses | n/a | n/a | 9.64B | 9.92B | 9.57B | 10.96B |
Cost & Expenses | 48.98B | 45.05B | 45.81B | 44.65B | 39.78B | 43.92B |
Income Tax Expense | 2.61B | 1.72B | 2.8B | 2.46B | 2.9B | 2.51B |
Shares Outstanding (Basic) | 802.31M | 803.49M | 800M | 850M | 855M | 856M |
Shares Outstanding (Diluted) | 802M | 804M | 800M | 860M | 865M | 864M |
EPS (Basic) | 10.39 | 14.40 | 15.53 | 16.39 | 16.72 | 15.77 |
EPS (Diluted) | 10.32 | 14.30 | 15.37 | 16.20 | 16.52 | 15.62 |
EBITDA | 16.62B | 18.54B | 24.07B | 24.33B | 23.08B | 21.7B |
EBIT | 13.2B | 15.08B | 20.57B | 20.25B | 18.52B | 17.41B |
Depreciation & Amortization | 3.42B | 3.46B | 3.5B | 4.08B | 4.57B | 4.31B |
Add to Watchlist
Select watchlists to add or remove RHHVF